Abstract:We have previously reported that a population of lymphoid-related CD8alpha(+) DEC-205(+) dendritic cells (DC) from mouse spleen have 'regulatory' effects on the T cells they activate. CD8 T cells produce IL-2 and give a sustained proliferative response to allogeneic CD8alpha(-) DEC-205(-) splenic DC, but produce little IL-2 and give a limited response to allogeneic CD8(+) DEC-205(+) splenic DC. Although CD8alpha and DEC-205 correlate closely among splenic DC, lymph nodes (LN) include a large population of CD8alpha(low) DEC-205(high) DC. By i.v. transfer of purified thymic early lymphoid precursors into irradiated recipient mice we now demonstrate that these CD8alpha(low) but DEC-205(high) LN DC can be the progeny of a lymphoid precursor population, apparently corresponding to the CD8alpha(high) DEC-205(high) DC progeny of the same precursors in spleen and thymus. By culture of the separated, purified DC with allogeneic CD8 T cells we demonstrate that the CD8alpha(low) DEC-205(high) DC of LN are also functionally equivalent to the CD8alpha(high) DEC-205(high) DC of spleen. Therefore, DEC-205 but not CD8alpha serves to segregate functionally distinct DC types in LN. However, DC isolated from the spleens of genetically manipulated DEC-205(null) mice and separated on the basis of CD8alpha expression have a similar capacity to stimulate CD8 T cells as their heterozygous littermate controls, with the CD8alpha(+) but now DEC-205(null) DC still giving restricted responses. In conclusion, high expression of DEC-205 appears to be a good marker of the lymphoid-related regulatory type of DC, but DEC-205 itself is not responsible for transmitting negative signals to the T cells.

RelB is Essential for the Development of Myeloid-Related CD8α− Dendritic Cells but Not of Lymphoid-Related CD8α+ Dendritic Cells

Opposing roles for RelB and Bcl-3 in regulation of T-box expressed in T cells, GATA-3, and Th effector differentiation

DEC-205 As a Marker of Dendritic Cells with Regulatory Effects on CD8 T Cell Responses.

Role of the NF-κB Family Member RelB in Regulation of Foxp3+ Regulatory T Cells in Vivo.

C-Rel is Required for the Development of Thymic Foxp3+ CD4 Regulatory T Cells

Dominant immune tolerance in the intestinal tract imposed by RelB-dependent migratory dendritic cells regulates protective type 2 immunity

Genomic deletion of Bcl6 differentially affects conventional dendritic cell subsets and compromises Tfh/Tfr/Th17 cell responses

The Transcription Factor RelB Restrains Group 2 Innate Lymphoid Cells and Type 2 Immune Pathology in Vivo.

Dendritic cells and T lymphocytes: developmental and functional interactions.

The Requirement of Membrane Lymphotoxin for the Presence of Dendritic Cells in Lymphoid Tissues

Development of Thymic and Splenic Dendritic Cell Populations from Different Hemopoietic Precursors

C‐rel is an Essential Transcription Factor for the Development of Acute Graft‐versus‐host Disease in Mice

Bcl6-Independent In Vivo Development of Functional Type 1 Classical Dendritic Cells Supporting Tumor Rejection

NIK-dependent RelB Activation Defines a Unique Signaling Pathway for the Development of Vα14i NKT Cells

Dendritic Cells Transduced with Lentiviral Vector Targeting RelB Gene Using RNA Interference Induce Hyporesponsiveness in Memory CD4(+) T Cells and Naïve CD4(+) T Cells.

Cd4 and Cd8 Expression by Dendritic Cell Subtypes in Mouse Thymus and Spleen

Inherited human c-Rel deficiency disrupts myeloid and lymphoid immunity to multiple infectious agents

Lentiviral-mediated Shrna Against RelB Induces the Generation of Tolerogenic Dendritic Cells.

Inherited human RelB deficiency impairs innate and adaptive immunity to infection

The Transcription Factors PU.1 and IRF4 Determine Dendritic Cell–Specific Expression of RALDH2